Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30004360
Basic Information
VIS ID
TVIS30004360
Fusion event
HIV-MEF2D integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr1
Cytoband
q22
Reference genome
GRCh37/hg19
Start
156447459/156477667 (Hg38)
End
156447459/156477667 (Hg38)
Orient
+
Location type
Intronic
Target gene
MEF2D
miRNAs that regulate target gene
hsa-mir-20a-5p
;
hsa-mir-17-5p
;
hsa-mir-99a-5p
;
hsa-mir-26b-5p
;
hsa-mir-19b-3p
;
hsa-mir-877-5p
;
hsa-mir-320a
;
hsa-let-7f-5p
;
hsa-mir-122-5p
;
hsa-mir-210-3p
;
hsa-mir-142-3p
;
hsa-mir-7109-5p
;
hsa-mir-4472
;
hsa-mir-4447
;
hsa-mir-6769b-5p
;
hsa-mir-6769a-5p
;
hsa-mir-92a-2-5p
;
hsa-mir-654-5p
;
hsa-mir-541-3p
;
hsa-mir-6835-5p
;
hsa-mir-6885-5p
;
hsa-mir-328-5p
;
hsa-mir-6887-5p
;
hsa-mir-6795-5p
;
hsa-mir-1255b-5p
;
hsa-mir-1255a
;
hsa-mir-4712-3p
;
hsa-mir-575
;
hsa-mir-4676-5p
;
hsa-mir-522-3p
;
hsa-mir-224-3p
;
hsa-mir-583
;
hsa-mir-524-5p
;
hsa-mir-520d-5p
;
hsa-mir-642b-3p
;
hsa-mir-642a-3p
;
hsa-mir-1324
;
hsa-mir-4789-3p
;
hsa-mir-6789-5p
;
hsa-mir-6813-5p
;
hsa-mir-6826-5p
;
hsa-mir-6085
;
hsa-mir-6743-5p
;
hsa-mir-4688
;
hsa-mir-335-5p
;
hsa-mir-3941
;
hsa-mir-603
;
hsa-mir-362-3p
;
hsa-mir-329-3p
;
hsa-mir-8485
;
hsa-mir-670-3p
;
hsa-mir-6881-3p
;
hsa-mir-6780a-3p
;
hsa-mir-7111-3p
;
hsa-mir-210-5p
;
hsa-mir-4749-3p
;
hsa-mir-324-3p
;
hsa-mir-1913
;
hsa-mir-1236-3p
;
hsa-mir-4685-3p
;
hsa-mir-4287
;
hsa-mir-3667-3p
;
hsa-mir-6747-3p
;
hsa-mir-6727-3p
;
hsa-mir-4722-3p
;
hsa-mir-877-3p
;
hsa-mir-5088-3p
;
hsa-mir-6887-3p
;
hsa-mir-32-5p
;
hsa-mir-92b-3p
;
hsa-mir-92a-3p
;
hsa-mir-18a-5p
;
hsa-mir-103a-3p
;
hsa-mir-19a-3p
;
hsa-let-7a-5p
;
hsa-let-7b-5p
;
hsa-let-7c-5p
;
hsa-let-7d-5p
;
hsa-let-7e-5p
;
hsa-let-7g-5p
;
hsa-let-7i-5p
;
hsa-mir-1207-5p
;
hsa-mir-1254
;
hsa-mir-1302
;
hsa-mir-1321
;
hsa-mir-1915-3p
;
hsa-mir-211-3p
;
hsa-mir-3116
;
hsa-mir-3153
;
hsa-mir-3170
;
hsa-mir-3173-3p
;
hsa-mir-3689d
;
hsa-mir-3929
;
hsa-mir-4259
;
hsa-mir-4270
;
hsa-mir-4298
;
hsa-mir-4419b
;
hsa-mir-4433a-3p
;
hsa-mir-4441
;
hsa-mir-4458
;
hsa-mir-4478
;
hsa-mir-4499
;
hsa-mir-4500
;
hsa-mir-4524b-3p
;
hsa-mir-4648
;
hsa-mir-4726-3p
;
hsa-mir-4739
;
hsa-mir-4756-5p
;
hsa-mir-485-5p
;
hsa-mir-5572
;
hsa-mir-5584-5p
;
hsa-mir-571
;
hsa-mir-6081
;
hsa-mir-6134
;
hsa-mir-615-5p
;
hsa-mir-6510-5p
;
hsa-mir-6733-5p
;
hsa-mir-6737-5p
;
hsa-mir-6739-5p
;
hsa-mir-6754-5p
;
hsa-mir-6761-5p
;
hsa-mir-6764-5p
;
hsa-mir-6768-5p
;
hsa-mir-6812-5p
;
hsa-mir-6819-5p
;
hsa-mir-6840-3p
;
hsa-mir-6851-5p
;
hsa-mir-6855-5p
;
hsa-mir-6884-5p
;
hsa-mir-6891-5p
;
hsa-mir-7156-3p
;
hsa-mir-7-5p
;
hsa-mir-7704
;
hsa-mir-9500
;
hsa-mir-98-5p
Nearest miRNA
hsa-mir-101-1/Upstream/57238; hsa-mir-1182/Downstream/458464;
Nearest TSS
ENST00000473358/Upstream/21090;
ENST00000564032/Downstream/2113;
Nearest CpG islands
None/Target,
chr1-CpG: 111/Upstream/20097
,
chr1-CpG: 112/Downstream/22158
Upstream sequence
TCTCCACAGACAGGAAGTCCAGCATTTTTAGGTCCCACAGTCTACCCCGGACAGGACCCACCATGACCAGGATGTGGAAGGGGTGGCAGCCTGGAATCCG
Downstream sequence
GGCCTCACTGAGAAGCCTGGTCACCATGACAAACCAACAACCACTCAGACTGCTCCATTTGCCGTGAGCTGGGGGTGGATGATGTGATTTGGATCAACAT
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Bcl-2 transduced CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate